To assess the relationship between asymmetric septal hypertrophy (ASH) and manifestations of coronary artery disease (CAD).
Introduction
Left ventricular (LV) hypertrophy (LVH) is common in patients with coronary artery disease (CAD). LVH was shown to be a compensatory response to acute or chronic ischaemia 1,2 and may co-exist with other cardiovascular comorbidities. 3 Asymmetric septal hypertrophy (ASH) is typically seen in patients with hypertrophic cardiomyopathy 4, 5 and among those with prior myocardial infarction (MI). 6 -8 However, in some patients with arterial hypertension 9 ( Figure 1 ), CAD per se may be associated with ASH without evidence of hypertrophic cardiomyopathy. The incidence and clinical significance of ASH in CAD has not been studied in depth. We therefore, evaluated the relationship between ASH and the clinical manifestations of CAD.
Methods

Study population
From February 1999 to May 2008, 5128 patients with significant CAD were retrospectively identified from admission records at the Tyumen Cardiology Center, Russia. CAD was defined using the criteria of the European Society of Cardiology and the American College of Cardiology. 10 Patients with acute MI, hypertrophic cardiomyopathy, and those with moderate to severe valvular heart disease were excluded. Sex, age, weight, height, body surface area (BSA), and obesity (defined as a body mass index .30 kg/m 2 ) at initial examination were recorded. Blood pressure was determined at baseline. Relevant information about previous arrhythmias were obtained from Holter monitoring data, and since 2005 from event-recorder examinations. MI was defined from ECG findings according to the Universal definition of MI. 11 Smoking and alcohol status were assessed by a questionnaire.
Echocardiography
Echo-Doppler images were analysed offline by two investigators; a third investigator blinded to the protocol was used to resolve any discrepancy in the diagnosis. ). LV hypertrophy (LVH) was to be considered present when the LV mass/BSA was .115 g/m 2 in men or .95 g/m 2 in women. 13 The extent of LV wall motion abnormalities and LV wall motion score index was identified. 15 ASH was considered significant if the ratio of ventricular septum thickness to LV posterior wall thickness was ≥1.3 4,16 ( Figure 2 ). Aortic atherosclerosis was identified by the visualization of increased echodensity or bright echoes on aortic walls and leaflets without restricted leaflet motion. Previous MI was identified by the presence of regional wall motion, thinning, or scar in the absence of other causes.
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Quantitative coronary angiography
Patients underwent elective coronary arteriography using standard projections ( Judkins, 1967) by Diagnost ARC A, Poly Diagnost C, and Integris Allura (Phillips, Holland). The minimal luminal diameter, average proximal and distal reference diameters, percentage stenosis, and lesion length were determined for each pair of orthogonal views and then averaged. Lesions were considered significant if stenosis severity was .50%.
Statistical analysis
Continuous variables are mean + SD. Distribution of ranges was identified by the Kolmogorov-Smirnov criterion. Results were compared using Student's t-test if the distribution was normal and using the Mann-Whitney U-test if the distribution was skewed. A multivariate analysis was performed using a forward stepwise logistic regression to determine independent predictive power of variables which showed significant intergroup differences. Statistical significance was taken at P , 0.05.
Results
Of the 5128 patients with CAD, 3764 (73.4%) had systemic hypertension and 2469 (48.2%) had LVH (age 54.4 + 7.6 years; male/ female ratio of 2188/281). Among patients with LVH, 297 (12%) had ASH and 2172 (88%) had symmetric LVH (SLVH). Baseline demographic and clinical characteristics for both groups are shown in Table 1 . When compared with the SLVH group, ASH patients were significantly older (P ¼ 0.001), and there were more males (P ¼ 0.004) and obese patients (P ¼ 0.029). The prevalence of severe heart failure (NYHA class III/IV) (P ¼ 0.006), frequency of prior MI (P , 0.001), systemic hypertension (P ¼ 0.006), and heart rhythm disorders (P ¼ 0.006) were higher in patients with ASH compared with patients with SLVH. There were no significant differences in frequencies of Canadian Cardiovascular System angina class III/IV, prevalence of smoking and alcohol, and plasma lipid levels between patients with ASH and SLVH. A difference in echocardiographic parameters was observed between the two groups ( Table 2) . LV and right ventricular (RV) end-diastolic dimensions, aortic root diameter, left atrial dimension, the extent of LV wall motion abnormalities, and the peak LV wall motion score index were significantly higher in patients with ASH than in those with SLVH (all P , 0.001). LV ejection Relationship between ASH and CAD fraction was significantly lower in ASH patients (P , 0.001). The frequency of impaired LV ejection fraction (,50%), moderate mitral regurgitation, signs of aortic atherosclerosis, and signs of previous MI were higher in ASH patients (all P , 0.001). LV mass was greater in ASH patients than in SLVH patients irrespective of whether it was expressed as absolute value or indexed to BSA (both P , 0.001).
Angiographic data demonstrated that the prevalence of right coronary artery (RCA) stenosis (P ¼ 0.001) and left circumflex artery (LCA) stenosis (P ¼ 0.027) and multiple stenoses (two or more vessels) (P ¼ 0.001) were higher in the group with ASH compared with SLVH patients. Severe (.90% stenosis) lesions of the RCA (P , 0.001) and LCA (P ¼ 0.048) were more frequent in ASH patients than in SLVH patients ( Table 3) .
Multivariate analysis (Table 4) identified that heart rhythm disorder, LV and RV end-diastolic dimension, aortic root diameter, impaired LV ejection fraction, echocardiographic signs of previous MI, severe lesion of the RCA, and LV mass were independently associated with ASH.
Discussion
Frequent occurrence of systemic hypertension caused high prevalence of LVH in our patients. A significant number of these patients had ASH. Previous studies suggested that ASH in patients with CAD may be secondary and may not be a manifestation of hypertrophic cardiomyopathy. Disorganized cardiac muscle cells, characteristically present in patients with hypertrophic cardiomyopathy, were absent from the septum of ASH patients studied at autopsy. 17 ASH development in patients with CAD may be a compensatory mechanism for diminishing contraction in another area of the heart that has undergone ischaemic injury.
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LV wall thickness measurements may be influenced by myocardial oedema. Acute MI causes the loss of myocyte membrane homeostasis leading to an imbalance between fluid content of the damaged area and surrounding areas. 18 Clinically significant myocardial oedema results in a 10% increase in ventricular wall thickness and 1 mm changes are reliably detected by echocardiography. 19 Investigations with magnetic resonance imaging showed that myocardial oedema is more pronounced at 1 week after MI, 20 and at first month after primary percutaneous coronary intervention. 21 In our study, acute MI patients were excluded, and not all patients had a history of prior MI. Therefore, influence of myocardial oedema on LV wall thickness measurements was insignificant.
An association between prior MI and ASH was demonstrated in the previous studies. 6 -8 Our data confirmed these results. In some of these studies, 6,7 the frequencies of ASH after prior MI were significantly higher (41.3 and 22%) than those in the present study (7.1%). This difference can be explained by the fact that in these studies, all patients were recovering from acute MI, and in the present study, as was said, acute MI patients were excluded, and not all patients had a history of prior MI. ASH development in patients with prior MI was associated with relative reduction of LV posterior wall thickness, and compensatory hypertrophy of the interventricular septum. 22 These patients had more preserved LV function, which was confirmed by a higher LV ejection fraction. 2 Our results were contrary to the previous studies. More severe heart failure, heart rhythm disorders, dilatation of heart chambers, extent of LV wall motion abnormalities, mitral regurgitation, and impaired LV ejection fraction occurred in CAD-ASH patients.
Prior MI is clearly important in the development of ASH in CAD. In our study, not all patients with ASH had a history of prior MI, and not all patients with prior MI even with inferior localization had ASH. Not only can acute MI with scarring induce compensatory hypertrophy of the interventricular septum, but chronic ischaemia can give the same result. Chronic myocardial hypoperfusion leads to myocardial hibernation. It combines with a decrease in the thickness of the myocardial wall and compensatory hypertrophy of the intact residual myocardium. 23 This compensatory hypertrophy can be observed proximally in an area of chronic reversible myocardial ischaemia. 24 Post-infarction LV remodelling includes heart chamber dilatation and myocardial hypertrophy. In the early post-MI period, these changes may have a compensatory role, but these changes can negatively affect LV function and survival in the long term. 25 We summarized the factors that lead to ASH in CAD in Figure 3 .
Our results indicate that ASH is a determinant of the unfavourable clinical manifestation of non-acute CAD.
The relationship between ASH and severe lesions of the RCA and LCA can predict a positive effect of coronary revascularization on myocardial remodelling, as suggested by some authors. 26 -28 This positive effect was observed in the severe changes in LV structure and function. 29 
Limitations
This study was limited by the weaknesses inherent in all retrospective investigations. A risk of information distortion during the collection and processing of data is omnipresent.
The next limitation was derived from the long observation period. Our study began in 1999. During these years, new generations of ultrasound systems were used in our investigation. Image quality from the beginning to the end of the study was variable. This could have influence on our conclusions based on the echocardiographic data. Relationship between ASH and CAD independent association of ASH with heart rhythm disorders, LV end-diastolic dimension, impaired LV ejection fraction, echocardiographic signs of previous MI, severe lesions of the RCA, and LV mass were demonstrated.
Conclusions
